Article
Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition
2025-09-21
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> At diagnosis, ∼80% of pancreatic ductal adenocarcinomas (PDAC) have metastasized. Relapse is thus common even among patients that undergo surgical resection, the only curative option. PDAC progresses rapidly, and existing immunotherapies have been ineffective. We hypothesized that natural killer (NK) cell immunotherapies could be effective against PDAC because they recognize...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bfb0f1b6-fe13-50d9-a847-f610b5fb69b3
- DOI
- 10.1101/2025.09.21.677560
